Paper31344409
Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
Mroz MS and 1 other. Steroids, 2019. Cited by 16 papers, by iCite.
Cite this record
ConductScience Library. Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells. Papers, record 31344409. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/31344409
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Ursodeoxycholic acid inhibits ENaC and Na/K pump activity to restore airway surface liquid height in cystic fibrosis bronchial epithelial cells.
- PubMed
Topics14
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Bronchi | Major topic |
| Cystic Fibrosis | Major topic |
| Epithelial Cells | Major topic |
| Epithelial Sodium Channels | Major topic |
| Sodium-Potassium-Exchanging ATPase | Major topic |
| Ursodeoxycholic Acid | Major topic |
| Cell Line | |
| Cystic Fibrosis Transmembrane Conductance Regulator | |
| Electrophysiological Phenomena | |
| Epithelial Sodium Channel Blockers | |
| Gene Expression Regulation, Enzymologic | |
| Humans | |
| Phenotype | |
| Surface Properties |
Source PubMed
Cited by13
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 16 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42939751 | Bile Acids and Their Receptors in Respiratory Diseases: Mechanistic and Therapeutic Perspectives. | Biomolecules | 2026 | https://conductscience.org/library/papers/42939751 | PubMed |
| 41239347 | Construction and application of a risk prediction model for sputum viscosity in patients with laryngeal malignant tumors after operation. | BMC Surg | 2025 | https://conductscience.org/library/papers/41239347 | PubMed |
| 41102022 | Ursodeoxycholic Acid Attenuates B Cell Susceptibility to SARS-CoV-2 Spike Protein by Interfering Its Binding to ACE2. | Biomol Ther (Seoul) | 2025 | https://conductscience.org/library/papers/41102022 | PubMed |
| 40115259 | Ursodeoxycholic and chenodeoxycholic bile acids alleviate endotoxininduced acute lung injury in rats by modulating aquaporin expression and pathways associated with apoptosis and inflammation. | Front Pharmacol | 2025 | https://conductscience.org/library/papers/40115259 | PubMed |
| 39109974 | Epithelial Na + Channels Function as Extracellular Sensors. | Compr Physiol | 2024 | https://conductscience.org/library/papers/39109974 | PubMed |
| 39026347 | Sex differences in airway disease: estrogen and airway surface liquid dynamics. | Biol Sex Differ | 2024 | https://conductscience.org/library/papers/39026347 | PubMed |
| 35658221 | Ursodeoxycholic acid ameliorates cell migration retarded by the SARS-CoV-2 spike protein in BEAS-2B human bronchial epithelial cells. | Biomed Pharmacother | 2022 | https://conductscience.org/library/papers/35658221 | PubMed |
| 35462606 | Downregulation of epithelial sodium channel (ENaC) activity in cystic fibrosis cells by epigenetic targeting. | Cell Mol Life Sci | 2022 | https://conductscience.org/library/papers/35462606 | PubMed |
| 35245132 | Bile acids and salt-sensitive hypertension: a role of the gut-liver axis. | Am J Physiol Heart Circ Physiol | 2022 | https://conductscience.org/library/papers/35245132 | PubMed |
| 34755536 | Contributions of bile acids to gastrointestinal physiology as receptor agonists and modifiers of ion channels. | Am J Physiol Gastrointest Liver Physiol | 2022 | https://conductscience.org/library/papers/34755536 | PubMed |
| 34680554 | Dysfunction in the Cystic Fibrosis Transmembrane Regulator in Chronic Obstructive Pulmonary Disease as a Potential Target for Personalised Medicine. | Biomedicines | 2021 | https://conductscience.org/library/papers/34680554 | PubMed |
| 34276407 | Nitric Oxide System and Bronchial Epithelium: More Than a Barrier. | Front Physiol | 2021 | https://conductscience.org/library/papers/34276407 | PubMed |
| 33916525 | DNA Methylation Patterns Correlate with the Expression of SCNN1A, SCNN1B, and SCNN1G (Epithelial Sodium Channel, ENaC) Genes. | Int J Mol Sci | 2021 | https://conductscience.org/library/papers/33916525 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| CFTR | 1080 | PubTator's text mining | https://conductscience.org/library/genes/1080 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/31344409
GET https://conductscience.org/api/papers/v1/31344409/authors